Cure Arthritis Naturally

Beat Arthritis Naturally

Get Instant Access

Abe Y, Seno A,Tada J,Arata J (1994) Discoid lupus erythematosus: successful treatment with oral methotrexate. Arch Dermatol 130:938-939 Abud-Mendoza C, Sturbaum AK,Vazquez-Compean R, Gonzalez-Amaro R (1993) Methotrexate therapy in childhood systemic lupus erythematosus. J Rheumatol 20:731-733 Abu-Shakra M, Buskila D (2002) Update on the treatment of systemic lupus erythematosus: therapeutic highlights from the Sixth International Lupus Conference. Isr Med Assoc J 4:71-73 Abu-Shakra M. Shoenfeld Y (2001) Azathioprine therapy for patients with systemic lupus erythematosus. Lupus 10:152-153 Arbisier JL, Moschella SL (1995) Clofazimine. A review of its medical uses and mechanisms of action. J Am Acad Dermatol 32:241-247 Asherson RA, Lahita RG (1991) Sex hormone modulation in systemic lupus erythematosus. Still a therapeutic option? Ann Rheum Dis 50:897-898 Ashinoff R, Werth VP, Frank AG Jr (1988) Resistant discoid lupus erythematosus of palms and soles: successful treatment with azathioprine. J Am Acad Dermatol 19:961-965 Ayers S Jr, Mihan R (1974) Lupus erythematosus and vitamin E: an effective and non-toxic therapy. Cutis 23:49-52

Bergman J, Rico MJ (2001) Tacrolimus clinical studies for atopic dermatitis and other conditions. Semin Cutan Med Surg 20:250-259 Boehm I, Bieber T (2001) Chilblain lupus erythematosus Hutchinson: successful treatment with mycophenolate mofetil. Arch Dermatol 137:235-236 Boehm IB, Boehm GA, Bauer R (1998) Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. Rheumatol Int 18:59-62

Bohm L, Uerlich M, Bauer R (1997) Rapid improvement of subacute lupus erythematosus with low-dose methotrexate. Dermatology 194:307-308

Bottomley WW, Goodfield MJ (1995a) Methotrexate for the treatment of discoid lupus erythematosus. Br J Dermatol 133:655-656 Bottomley WW, Goodfield MJ (1995b) Methotrexate for the treatment of severe mucocutaneous lupus erythematosus. Br J Dermatol 133:311-314 Burkhardt H, Kalden JR (1997) Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases. Rheumatol Int 17:85-90 Callen JP (2002) Management of skin disease in patients with lupus erythematosus. Best Pract

Res Clin Rheumatol 16:245-264 Callen JP, Spencer LV, Burruss JB, Holtman J (1991) Azathioprine: an effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol 127:515-522 Carmichael AJ, Paul CJ (1991) Discoid lupus erythematosus responsive to sulphasalazine. Br J Dermatol 125:291-294

Cohen Y, Nagler A (2002) Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support. Isr Med Assoc J 4:865-867 Conti F, Priori R, Alessandri C, Spinelli FR, Medda E, Valesini G (2000) Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine A. Lupus 9:676-680 Cronstein BN (1996) Molecular therapeutics. Methotrexate and its mechanism of action.Arthri-

tis Rheum 39:1951-1960 Dalziel K, Going G, Cartwright PH, Marks R, Beveridge GW, Rowell NR (1986) Treatment of chronic discoid lupus erythematosus with an oral gold component (auranofin). Br J Derma-tol 115:211-216

De Vita S, Ferraccioli GF, Di Poi E, Bartoli E, Bombardieri S (1996) High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience. Clin Exp Rheumatol 14:S85-92 DeBandt M, Descamps V, Meyer O (2001) Etanercept-induced systemic lupus erythematosus:

two cases on patients with rheumatoid arthritis. Lupus 10:S118 Delaporte E, Catteau B, Sabbagh N, Gosselin P, Breuillard F, Doutre M-S, Broly F, Piette F, Ber-goend H (1997) Traitement du lupus erythemateux chronique par la sulfasalazine: 11 observations. Ann Dermatol Venereol 124:151-156 Dequet CR, Wallace DJ (2001) Novel therapies in the treatment of systemic lupus erythematosus. Curr Opin Investig Drugs 2:1045-1053 Duddridge M, Powell RJ (1997) Treatment of severe and difficult cases of systemic lupus ery-

thematosus with tacrolimus. A report of three cases. Ann Rheum Dis 56:690-692 Duna GF, Cash JM (1995) Treatment of refractory cutaneous lupus erythematosus. Rheum Dis

Clin North Am 21:99-115 Dutz JP, Ho VC (1998) Immunosuppressive agents in dermatology. An update. Dermatol Clin 16:235-251

Englert HJ, Hughes GVR (1988) Danazol and discoid lupus. Br J Dermatol 119:407-409 Ferda A (1996) Efficacy of sulfasalazine in discoid lupus erythematosus. Int J Dermatol 10:746-748 Furst DE (1999) Leflunomide, mycophenolic acid and matrix metalloproteinase inhibitors.

Rheumatology (Oxford) 38:14-18 Furst DE (2002) Stem cell transplantation for autoimmune disease: progress and problems. Curr

Opin Rheumatol 14:220-224 Furukawa F, Imamura S, Takigawa M (1995) FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. Arch Dermatol Res 287:558-563 Garcia-Porrua C, Gonzales Gay MA, Fernandez-Lamelo F, Paz-Carreira JM, Lavilla E, GonzalesLopez MA (1998) Simultaneous development of SLE-like syndrome and autoimmune thy-roiditis following alpha-interferon treatment. Clin Exp Rheumatol 16:107-108 Gasparro FP (2000) Photodermatology: progress, problems and prospects. Eur J Dermatol 10: 250-254

Gelfand EW (2001) Antibody-directed therapy: Past, present and future. J Allergy Clin Immunol 108:111-116

Genereau T, Chosidow O, Danel C, Cherin P, Herson S (1999) High-dose intravenous immunoglobulin in cutaneous lupus erythematosus. Arch Dermatol 135:1124-1125 Gescuk BD, Davis JC Jr (2002) Novel therapeutic agents for systemic lupus erythematosus. Curr

Opin Rheumatol 14:515-521 Glant TT, Mikecz K, Brennan F, Negroiu G, Bartlett R (1998) Suppression of autoimmune responses and inflammatory events by leflunomide in an animal model for rheumatoid arthritis. J Rheumatol 25:20-26 Goldberg JW, Lidsky MD (1984) Pulse methylprednisolone therapy for persistent subacute cutaneous lupus. Arthritis Rheum 27:837-838 Goldstein E, Carey W (1994) Discoid lupus erythematosus: successful treatment with oral methotrexate. Arch Dermatol 130:938-939 Goyal S, Noussari HC (2001) Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil. J Am Acad Dermatol 45:142-144 Graninger WB, Hassfeld W, Pesau BB, Machold KP, Zielinski CC, Smolen JS (1991) Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis. J Reumatol 18:1621-1622

Gratwohl A, Passweg J, Gerber I, Tyndall A (2001) International Stem Cell Project for Autoimmune Diseases. Stem cell transplantation for autoimmune diseases. Best Pract Res Clin Haematol 14:755-776

Griffiths B, Emery P (2001) The treatment of lupus with cyclosporine A. Lupus 10:165-170 Hanjani NM, Noussari CH (2002) Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement. Arch Dermatol 138:1616-1618 Hazelton RA, McCruden AB, Sturrock RD, Stimson WH (1983) Hormonal manipulation of the immune response in systemic lupus erythematosus: a drug trial of an anabolic steroid, 19-nortestosterone. Ann Rheum Dis 42:155-157 Isaacs JD (2001) From bench to bedside: discovering rules for antibody design, and improving serotherapy with monclonal antibodies. Rheumatol 40:724-738 Isenberg D, Leckie MJ (2002) Biological treatments for systemic lupus erythematosus. Scand J Rheumatol 31:187-191

Jansen GT, Dillaha CJ, Honeycutt WM (2001) Discoid lupus erythematosus. Is systemic treatment necessary? Arch Dermatol 92:283-285 Jayne D (1999) Non-transplant uses of mycophenolate mofetil. Curr Opin Nephrol Hypertens 8:563-567

Jeffes EW 3rd,McCullough JL, Pittelkow MR, McCormick A, Almanzor J,Liu G (1995) Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth - inhibitory effects of methotrexate. J Invest Dermatol 104: 183-188

Jessop S, Whitelaw D, Jordaan F (2001) Drugs for discoid lupus erythematosus. Cochrane Database Syst Rev CD002954 Jolles S, Hughes J, Whittaker S (1998) Dermatological uses of high-dose intravenous immuno-

globulin. Arch Dermatol 134:80-86 Jungers P, Kuttenn F, Liote F, Pelissier C, Athea N, Laurent MC, Viriot J, Dougados M, Bach JF (1985) Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate. Arthritis Rheum 28:1243-1250 Karim MY, Alba P, Cuadrado MJ, Abbs IC, D'Cruz DP, Khamashta MA, Hughes GR (2002) Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford) 41:876-882 Kilian K, Banyai A, Karadi A, Miklos K, Patranyi GG, Paloczi K (1998) FK-506 (tacrolimus) therapy for an unusual SLE-like disease. Transplant Proc 30:4130-4131 Knobler RM, Graninger W, Lindmaier A, Trautinger F, Smolen JS (1992) Extracorporeal pho-tochemotherapy for the treatment of systemic lupus erythematosus. A pilot study. Arthrit Rheum 32:319-324

Krivanek JFC, Paver WKA (1980) Further studies on the use of clofazimine in discoid lupus ery-thematosus. Australas J Dermatol 21:169-171

Kuhn A, Specker C, Ruzicka T, Lehmann P (2002) Methotrexate treatment for refractory subacute cutaneous lupus erythematosus. J Am Acad Dermatol 46:600-603 Kurtz ES, Bayley SC, Arshad F, Lee AA, Przekop PA (1995) Leflunomide: an active antiinflammatory and antiproliferative agent in models of dermatologic disease. Inflamm Res 44:187-188

Lernia VD, Bisighini G (1996) Discoid lupus erythematosus during treatment with cyclosporine.

Acta Derm Venereol 76:87-88 Luger T (2001) Treatment of immune-mediated skin diseases: future perspectives. Eur J Dermatol 11:343-347

Machlod KP, Smolen JS (1990) Interferon-gamma induced exacerbation of systemic lupus erythematosus. J Rheumatol 17:831-832 Martinez J, de Misa RF, Torrelo A, Ledo A (1992) Low-dose intralesional interferon alfa for discoid lupus erythematosus. J Am Acad Dermatol 26:494-496 Martinez J, de Misa RF, Boixeda P, Arrazola JM, Ledo A (1993) Long-term results of intralesional interferon alpha-2B in discoid lupus erythematosus. J Dermatol 20:444-446 Masse R, Youinou P, Dorval JC, Cledes J (1980) Reversal of lupus-erythematosus-like disease with danazol. Lancet 20:651 McCauliffe DP (2001) Cutaneous lupus erythematosus. Semin Cutan Med Surg 20:14-26 McGrath HJ (1994) Ultraviolet A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 12:129-135 McGrath H Jr (1997) Prospects for UV-A1 therapy as a treatment modality in cutaneous and systemic LE: Lupus 6:209-217 McGrath HJ (1999) Ultraviolet A1 (340-400 nm) irradiation and systemic lupus erythematosus.

J Invest Dermatol 4:79-84 McGrath HJ, Bak E, Michalski JP (1987) Ultraviolet-A light prolongs survival and improves immune function (New Zealand black x New Zealand white) F1 hybrid mice. Arthritis Rheum 30:557-561 1

McGrath HJ, Martinez-Osuna P, Lee FA (1996) Ultraviolet A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus. Lupus 5:269-274 Millard TP, Hawk JLM (2001) Ultraviolet therapy in lupus. Lupus 10:185-187 Molina N, McGrath HJr. Longterm ultraviolet A1 irradiation therapy in systemic lupus erythe-

matosus. J Rheumatol 24:1072-1074 Moore J, Tyndall A, Brooks P (2001) Stem cells in the aetiopathogenesis and therapy of rheumatic disease. Best Pract Res Clin Rheumatol 15:711-726 Morley KD, Parke A, Hughes GRV (1982) Systemic lupus erythematosus: two patients treated with danazol. Br Med J 284:1431-1432 Morris LF, Lemak NA, Arnett FC Jr, Jordon RE, Duvic M (1996) Systemic lupus erythematosus diagnosed during interferon alfa therapy. South Med J 89:810-814 Nicolas JF, Thivolet J (1989) Interferon alpha therapy in severe unresponsive subacute cutaneous lupus erythematosus. N Engl J Med 321:1550-1551 Nicolas JF, Thivolet J, Kanitakis J, Lyonnet S (1990) Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a. J Invest Dermatol 95:142S-145S Nousari HC, Kimyai-Asadi A, Tausk FA (1998) Subacute cutaneous lupus erythematosus associated with interferon beta-1a. Lancet 352:1925-1825 Obermoser G, Weber F, Sepp N (2001) Discoid lupus erythematosus in a patient receiving cyclosporin for liver transplantation. Acta Derm Venereol 81:319 Openshaw H, Nash RA, McSweeney PA (2002) High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical review. Biol Blood Marrow Transplant 8:233-248

Parnham MJ (1995) Leflunomide: a potential new disease modifying anti-rheumatic drug. Exp

Opin Invest Drugs 4:777-779 Patel PP, Werth V (2002) Cutaneous lupus erythematosus: a review. Dermatol Clin 20:373-385 Piette JC (1995) High-dose immunoglobulins in the treatment of refractory cutaneous lupus erythematosus. Open trial in 5 cases. Arthritis Rheum 38:S304

Piette JC, Du LT, Papo T (1995) Postmenopausal hormone therapy and systemic lupus erythematosus. Ann Intern Med 122:961-962 Pisetksky DS (2000) Tumor necrosis a blockers and the induction of anti-DNA autoantibodies.

Arthritis Rheum 43:2381-2382 Prinz JC, Meurer M, Reiter C, Rieber EP, Plewig G, Riethmuller G (1996) Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412. J Am Acad Dermatol 34:244-252 Reid C (2000) Drug treatment of cutaneous lupus.Am J Clin Dermatol 1:375-379 Remer CF, Weisman MH, Wallace DJ (2001) Benefits of leflunomide in systemic lupus erythe-

matosus: a pilot observational study. Lupus 10:480-483 Richter HI, Krutmann J, Goerz G (1998) Extrakorporale Photopherese bei therapie-refraktärem disseminiertem diskoiden Lupus erythematodes. Hautarzt 49:487-491 Robert C, Kupper TS (1999) Inflammatory skin diseases, T cells and immune surveillance. N

Engl J Med 341:1817-1828 Rodriquez-Castellanos MA, Rubio JB, Gomez JFB, Mendoza AG (1995) Phenytoin in the treatment of discoid lupus erythematosus. Arch Dermatol 131:620-621 Ronnblom LE, Alm GV, Oberg KE (1991a) Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 115:178-183 Ronnblom LE, Alm GV, Oberg KE (1991b) Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment. Acta Oncol 30:537-540 Rothenberg RJ, Graziano FM, Grandone JT, Goldberg JW, Bjarnason DF, Finesilver AG (1988) The use of methotrexate in steroid-resistant systemic lupus erythematosus.Arthritis Rheum 31:612-615

Rudnicka L, Szymanska E, Walecka I, Slowinska M (2000) Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. Dermatology 200:129-131 Russell-Jones R (2000) Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies. Br J Dermatol 142:16-21 Rutter A, Luger T (2001) High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin. J Am Acad Dermatol 44:1010-1024

Sacher RA (2001) Intravenous immunoglobulin consensus statement. J Allergy Clin Immunol 108:139-146

Saeki Y, Oshima S, Kurimoto I, Miura H, Suemura M (2000) Maintaining remission of lupus erythematosus profundus (LEP) with cyclosprin A. Lupus 9:390-392 Schanz S, Ulmer A, Rassner G, Fierlbeck G (2002) Successful treatment of subacute lupus erythematosus with mycophenolate mofetil. Br J Dermatol 147:174-178 Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M (1991) Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 68:1536-1537

Schulz EJ, Menter MA (1971) Treatment of discoid and subacute cutaneous lupus erythemato-

sus with cyclophosphamide. Br J Dermatol 85:60-65 Singer NG, McCune WJ (1998) Update on immunosuppressive therapy. Curr Opin Rheumatol 10:169-173

Solsky M,Wallace DJ (2002) New therapies in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 16:293-312

Sonnichsen N, Meffert H, Kunzelmann V, Audring H (1993) UV-A-1 therapy of subacute cutaneous lupus erythematosus. Hautarzt 44:723-725 Steinkjer B (1995) Auranofin in the treatment of discoid lupus erythematosus. J Dermatol Treat


Sticherling M (2001) Chronic cutaneous lupus erythematosus. In: Hertl M (ed) Autoimmune disease of the skin - pathogenesis, diagnosis, management. Springer, Vienna Berlin Heidelberg New York, pp 337-364 Sturgess AD, Evans DT,Mackay IR, Riglar A (1984) Effects of the oestrogen antagonist tamoxifen on disease indices in systemic lupus erythematosus. J Clin Lab Immunol 13:11-14

Tan BB, Lear TJ, Gawkrodger DJ, English JS (1997) Azathioprine in dermatology: a survey of current practice in the UK. Br J Dermatol 136:351-355 Thivolet J, Nicolas JF, Kanitakis J, Lyonnet S, Chouvet B (1990) Recombinant interferon alpha 2a is effective in the treatment of discoid and subacute cutaneous lupus erythematosus. Br J Dermatol 122:405-409

Thoma-Uszynski S, Hertl M (2001) Novel therapeutic approaches in autoimmune skin disorders. In: Hertl M (ed) Autoimmune disease of the skin - pathogenesis, diagnosis, management. Springer, Vienna Berlin Heidelberg New York, pp 337-364 Torrelo A, Espana A, Medina S, Ledo A (1990) Danazol and discoid lupus erythematosus. Dermatologica 181:239

Tran QHD, Guay E, Chartier S,Tousignant J (2001) Tacrolimus in dermatology. J Cutan Med Surg 5:329-335

Traynor AE, Barr WG, Rosa RM, Rodriguez J, Oyama Y, Baker S, Brush M, Burt RK (2002) Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. Arthritis Rheum 46:2917-2923 Tsokos GC, Caughman SW, Klippel JH (1985) Successful treatment of generalized discoid lesions with azathioprine. Its use in a patient s with systemic lupus erythematosus. Arch Dermatol 121:1323-1325

Tyndall A, Koike T (2002) High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future direction. Intern Med 41:608-612

Tyndall A, Passweg J, Grathwohl A (2000) Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases. Ann Rheum Dis 60:702-707 Walker SL, Kirby B, Chalmers RJ (2002) The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol 147:405-406 Wallace D (2001) Current and emerging lupus treatments. Am J Manag Care 7:S490-495 Wallace DJ (2002) Management of lupus erythematosus: recent insights. Curr Opin Rheumatol 14:212-219

Warner LM, Cummons T, Nolan L, Sehgal SN (1995) Sub-therapeutic doses of sirolimus and cyclosporin A in combination reduce SLE pathologies in the MRL mouse. Inflamm Res 44:S205-206

Watts RA (2000) Musculoskeletal and systemic reactions to biological therapeutic agents. Curr

Opin Rheumatol 12:49-54 Werth V (2001) Current treatment of cutaneous lupus erythematosus. Dermatol Online J 7:2-12 Werth VP (1993) Management and treatment with systemic glucocorticoids. Adv Dermatol 8:81-101

Wilder RL (1998) Hormones, pregnancy, and autoimmune diseases. Ann NY Acad Sci. 840:45-50 Wilke WS, Krall PL, Scheetz RJ, Babiak T, Danao T, Mazanec DJ, Segal AM, Clough JD (1991) Methotrexate for systemic lupus erythematosus: a retrospective analysis of 17 unselected cases. Clin Exp Rheumatol 9:581-587 Wollina U, Looks A (1999) Extracorporeal photochemotherapy in cutaneous lupus erythematosus. J Eur Acad Dermatol Venereol 13:127-130 Yell JA, Burge SM (1994) Cyclosporine and discoid lupus erythematosus. Br J Dermatol 131:132-133

Yocum DE (1996) Cyclosporine, FK-506, rapamycin, and other immunomodulators. Rheum Dis

Clin North Am 22:133-154 Yoshimasu T, Ohtani T, Sakamoto T, Oshima A, Furukawa F (2002) Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermato-myositis. Eur J Dermatol 12:50-52

Was this article helpful?

0 0
Natural Arthritis Relief

Natural Arthritis Relief

Natural Arthritis Relief details a unique method of reversing Rheumatoid Arthritis Symptoms by removing numerous arthritis triggers as well as toxins using a simple 5 step natural process.

Get My Free Ebook

Post a comment